MacroGenics
MGNX
#9151
Rank
NZ$0.19 B
Marketcap
NZ$3.04
Share price
-5.18%
Change (1 day)
-43.59%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): NZ-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is NZ-$0.08302. In 2024 the company made an earnings per share (EPS) of NZ-$1.78 a decrease over its 2023 EPS that were of NZ-$0.25.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.20-88.87%
2024NZ-$1.78613.33%
2023NZ-$0.25-92.31%
2022NZ-$3.24-42.14%
2021NZ-$5.6036.44%
2020NZ-$4.10-21.84%
2019NZ-$5.25-24.58%
2018NZ-$6.96675.93%
2017NZ-$0.90-68.05%
2016NZ-$2.81168.25%
2015NZ-$1.05-55%
2014NZ-$2.323400%
2013NZ-$0.06642-108.68%
2012NZ$0.7724.49%
2011NZ$0.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.86-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$34.07-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$21.64-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$10.83-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.61-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.93-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$2.94 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA